Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies
Author:
Affiliation:
1. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA (Z.R.M., L.J.W.).
2. Department of Statistics and Actuarial Science, The University of Hong Kong, China (G.Y.).
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference5 articles.
1. Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results
2. Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies
3. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
4. Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease
5. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Estimands in clinical trials of complex disease processes;Clinical Trials;2024-08-24
2. Time-Varying Cardiovascular Effects of Complete Versus Culprit Vessel Revascularization Among Older Adults With Myocardial Infarction;JACC: Advances;2024-08
3. Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement;International Journal of Clinical Oncology;2024-07-08
4. Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi‐institutional study;International Journal of Urology;2024-05-31
5. Moderate Aortic Valve Stenosis Is Associated With Increased Mortality Rate and Lifetime Loss: Systematic Review and Meta‐Analysis of Reconstructed Time‐to‐Event Data of 409 680 Patients;Journal of the American Heart Association;2024-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3